Proteomic analysis shows down-regulations of cytoplasmic carbonic anhydrases, CAI and CAII, are early events of colorectal carcinogenesis but are not correlated with lymph node metastasis

Tumori

Volumn 98, Issue 6, 2012, Pages 783-791

  Wang, Ning ^a   Chen, Yang ^a   Han, Yuchen ^a   Zhao, Yue ^a   Liu, Yu ^a   Guo, Kejian ^a   Jiang, Yi ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Carbonic anhydrase I; Carbonic anhydrase II; Colorectal cancer; Proteomics

Indexed keywords

CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SCREENING; CANCER STAGING; CARCINOGENESIS; COLORECTAL CANCER; COLORECTAL POLYP; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENZYME ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR DIAGNOSIS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEOMICS; TUMOR DIFFERENTIATION; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; CARBONIC ANHYDRASE I; CARBONIC ANHYDRASE II; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; LYMPH NODES; LYMPHATIC METASTASIS; PROTEOME; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 84873619450     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161209800617     Document Type: Article

References (26)

1. Weitz J, Koch M, Debus J, Höhler T, Galle PR, Büchler MW: Colorectal cancer. Lancet, 365: 153-165, 2005.
2. Kim SS, Hur SY, Kim YR, Yoo NJ, Lee SH: Expression of AIMP1, 2 and 3, the scaffolds for the multi-tRNA synthetase complex, is downregulated in gastric and colorectal cancer. Tumori, 97: 380-385, 2011.
3. Mazzanti R, Solazzo M, Fantappié O, Elfering S, Pantaleo P, Bechi P, Cianchi F, Ettl A, Giulivi C: Differential expression proteomics of human colon cancer. Am J Physiol Gastrointest Liver Physiol, 290: G1329-1338, 2006.
4. Ma Y, Peng J, Liu W, Zhang P, Huang L, Gao B, Shen T, Zhou Y, Chen H, Chu Z, Zhang M, Qin H: Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer. Mol Cell Proteomics, 8: 1878-1890, 2009.
5. Bi X, Lin Q, Foo TW, Joshi S, You T, Shen HM, Ong CN, Cheah PY, Eu KW, Hew CL: Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis. Mol Cell Proteomics, 5: 1119-1130, 2006.
6. Hosako M, Muto T, Nakamura Y, Tsuta K, Tochigi N, Tsuda H, Asamura H, Tomonaga T, Kawai A, Kondo T: Proteomic study of malignant pleural mesothelioma by laser microdissection and two-dimensional difference gel electrophoresis identified cathepsin D as a novel candidate for a differential diagnosis biomarker. J Proteomics, 75: 833-844, 2012.
7. Alessandro R, Fontana S, Kohn E, De Leo G: Proteomic strategies and their application in cancer research. Tumori, 91: 447-455, 2005.
8. Alfonso P, Núñez A, Madoz-Gurpide J, Lombardia L, Sánchez L, Casal JI: Poteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics, 5: 2602-2611, 2005.
9. Cook LA, Schey KL, Wilcox MD, Dingus J, Ettling R, Nelson T, Knapp DR, Hildebrandt JD: Proteomic analysis of bovine brain G protein gamma subunit processing heterogeneity. Mol Cell Proteomics, 5: 671-685, 2006.
10. Rodríguez-Piñeiro AM, de la Cadena MP, López-Saco A, Rodríguez-Berrocal FJ: Differential expression of serum clusterin isoforms in colorectal cancer. Mol Cell Proteomics, 5: 1647-1657, 2006.
11. Friedman DB, Hill S, Keller JW, Merchant NB, Levy SE, Coffey RJ, Caprioli RM: Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics, 4: 793-811, 2004.
12. Gilmour KM: Perspectives on carbonic anhydrase. Comp Biochem Physiol A Mol Integr Physiol, 157: 193-197, 2010.
13. Zimmerman SA, Ferry JG: The beta and gamma classes of carbonic anhydrase. Curr Pharm Des, 14: 716-721, 2008.
14. Potter CP, Harris AL: Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer. Br J Cancer, 89: 2-7, 2003.
15. Kummola L, Hämäläinen JM, Kivelä J, Kivelä AJ, Saarnio J, Karttunen T, Parkkila S: Expression of a novel carbonic anhydrase, CA XIII, in normal and neoplastic colorectal mucosa. BMC Cancer, 5: 41, 2005.
16. Supuran CT: Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov, 7: 168-181, 2008.
17. Fliedner SM, Kaludercic N, Jiang XS, Hansikova H, Hajkova Z, Sladkova J, Limpuangthip A, Backlund PS, Wesley R, Martiniova L, Jochmanova I, Lendvai NK, Breza J, Yergey AL, Paolocci N, Tischler AS, Zeman J, Porter FD, Lehnert H, Pacak K: Warburg effect's manifestation in aggressive pheochromocytomas and paragangliomas: insights from a mouse cell model applied to human tumor tissue. PLoS One, 7: e40949, 2012.
18. Larson SM: Positron emission tomography-based molecular imaging in human cancer: exploring the link between hypoxia and accelerated glucose metabolism. Clin Cancer Res, 10: 2203-2204, 2004.
19. Fang JS, Gillies RD, Gatenby RA: Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Semin Cancer Biol, 18: 330-337, 2008.
20. Guadagni S, Kanavos E, Schietroma M, Fiorentini G, Amicucci G: Selected hypoxic stop-flow perfusions: indication and limits. Tumori, 92: 402-406, 2006.
21. Lindner D, Raghavan D: Intra-tumoural extra-cellular pH: a useful parameter of response to chemotherapy in syngeneic tumour lines. Br J Cancer, 100: 1287-1291, 2009.
22. Gillies RJ, Raghunand N, Garcia-Martin ML, Gatenby RA: pH imaging. A review of pH measurement methods and applications in cancers. IEEE Eng Med Biol Mag, 23: 57-64, 2004.
23. Beltrán AR, Ramírez MA, Carraro-Lacroix LR, Hiraki Y, Rebouças NA, Malnic G: NHE1, NHE2, and NHE4 contribute to regulation of cell pH in T84 colon cancer cells. Pflugers Arch, 455: 799-810, 2008.
24. Kivela AJ, Saarnio J, Karttunen TJ, Hiraki Y, Rebouças NA, Malnic G: Differential expression of cytoplasmic carbonic anhydrases, CA I and II, and membrane-associated isozymes, CA IX and XII, in normal mucosa of large intestine and in colorectal tumors. Dig Dis Sci, 46: 2179-2186, 2001.
25. Bekku S, Mochizuki H, Yamamoto T, Ueno H, Takayama E, Tadakuma T: Expression of carbonic anhydrase I or II and correlation to clinical aspects of colorectal cancer. Hepatogastroenterology, 47: 998-1001, 2000.
26. Niemelä AM, Hynninen P, Mecklin JP, Kuopio T, Kokko A, Aaltonen L, Parkkila AK, Pastorekova S, Pastorek J, Waheed A, Sly WS, Orntoft TF, Kruhøffer M, Haapasalo H, Parkkila S, Kivelä AJ: Carbonic anhydrase IX is highly expressed in hereditary nonpolyposis colorectal cancer. Cancer Epidemiol Biomarkers Prev, 16: 1760-1766, 2007.